In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Prepares To Issue Regulatory Guidance For Nanotechnology Devices

This article was originally published in The Gray Sheet

Executive Summary

FDA should develop guidance for products that use nanotechnology and take steps to address the risks and benefits of the emerging technology, a July 25 agency task force report recommends

You may also be interested in...



Nanotech: FDA Seeks Input On Needed Device Tests, Defends Budget Request

FDA will seek advice next month on the types of pre-clinical tests it should require for devices that incorporate nanotechnology

Nanotech: FDA Seeks Input On Needed Device Tests, Defends Budget Request

FDA will seek advice next month on the types of pre-clinical tests it should require for devices that incorporate nanotechnology

CDRH Urges Input As It Drafts Guidance On Devices Made With Nano Materials

Forthright feedback from industry could accelerate regulatory timelines for medical devices incorporating nanoscale materials, say FDA officials working to draft guidance on pre-market review of the devices

Related Content

UsernamePublicRestriction

Register

MT025071

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel